LATANO SANTEN OPHTHALMIC SOLUTION 0.005%wv

Држава: Сингапур

Језик: Енглески

Извор: HSA (Health Sciences Authority)

Активни састојак:

Latanoprost

Доступно од:

SANTEN PHARMACEUTICAL ASIA PTE. LTD.

АТЦ код:

S01EE01

Фармацеутски облик:

SOLUTION, STERILE

Састав:

Latanoprost 0.005%w/v

Пут администрације:

OPHTHALMIC

Тип рецептора:

Prescription Only

Произведен од:

Santen Pharmaceutical Co., Ltd. Noto Plant

Статус ауторизације:

ACTIVE

Датум одобрења:

2023-08-31

Карактеристике производа

Prostaglandin F
2α
analogue
For prescription use only
LATANO SANTEN
(LATANOPROST OPHTHALMIC SOLUTION 0.005%W/V)
[CONTRAINDICATION]
Known
hypersensitivity
to
latanoprost
or
any
other
component of the product.
[DESCRIPTION]
Brand name
Latano Santen
Active ingredient
Latanoprost
Content per mL
50 µg
Excipients
Polysorbate 80, sodium chloride, dibasic sodium phosphate hydrate,
sodium dihydrogen phosphate dihydrate, benzalkonium chloride,
sodium hydroxide, phosphoric acid and purified water
pH
6.5 - 6.9
Osmolar ratio
0.9 - 1.0
Description
Clear, colorless, sterile, aqueous ophthalmic solution
[INDICATIONS]
Reduction of elevated intraocular pressure (IOP) in patients with
open-angle glaucoma and ocular hypertension. It
may also be used for the reduction of elevated intraocular pressure as
an adjunct medical therapy in patients with
primary chronic angle closure glaucoma.
Reduction of elevated intraocular pressure in paediatric patients with
elevated intraocular pressure and paediatric
glaucoma.
[DOSAGE AND ADMINISTRATION]
Instill one drop in the affected eye(s) once daily.
Optimal effect is obtained if latanoprost is administered in the
evening.
The dosage of latanoprost should not exceed once daily since it has
been shown that more frequent administration
decreases the IOP lowering effect.
If one dose is missed, treatment should continue with the next dose as
normal.
Latanoprost may be used concomitantly with other classes of topical
ophthalmic drug products to lower IOP. If more
than one topical ophthalmic drug is being used, the drugs should be
administered at least five minutes apart.
Contact lenses should be removed before instillation of the eye drops
and may be reinserted after fifteen minutes
Paediatric population
Latanoprost eye drops may be used in paediatric patients at the same
posology as in adults. No data are available for
preterm infants (less than 36 weeks gestational age). Data in the age
group <1 year (4 patients) are limited (see section
PRECAUTIONS FOR USE
).
Page: 1 of 9
[PRECAUTIONS FOR USE]
1.